Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Alfresa Holdings Corp
2784Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan. Address: 1-1-3 Otemachi, Tokyo, Japan, 100-0004
Analytics
Zielpreis von Wall Street
354 461.29 JPYKGV
13.145Dividendenrendite
1.75 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 2784
Dividenden-Analyse 2784
Dividendenwachstum über 5 Jahre
48 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
29 %Verlauf der Dividende 2784
Bewertung der Aktie 2784
Finanzen 2784
Ergebnisse | 2019 | Dynamik |